Citrine Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Citrine Capital's JNJ Position: Q3 2026 in Review
Citrine Capital increased its Johnson & Johnson (JNJ) stake by 0.53% in Q3 2026, buying an estimated $14.5K and bringing the position to 10,523 shares worth $2.79M. The position accounts for 0.94% of the portfolio, ranked #12.
Citrine Capital first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,716 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.
- Citrine Capital held 10,523 shares of Johnson & Johnson worth $2.79M as of Q3 2026.
- Citrine Capital bought 55 Johnson & Johnson shares in Q3 2026, an estimated $14.5K.
- Johnson & Johnson made up 0.94% of Citrine Capital's portfolio in Q3 2026, its #12 holding.
- Citrine Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
- 4,716 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.
Based on Citrine Capital's 13F filing for Q3 2026, filed 14 Oct 2026.